Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Kidney Int ; 90(1): 135-48, 2016 07.
Article in English | MEDLINE | ID: mdl-27217195

ABSTRACT

There is a great need for treatment that arrests progression of chronic kidney disease. Increased albumin in urine leads to apoptosis and fibrosis of podocytes and tubular cells and is a major cause of functional deterioration. There have been many attempts to target fibrosis, but because of the lack of appropriate agents, few have targeted apoptosis. Our group has described an ouabain-activated Na,K-ATPase/IP3R signalosome, which protects from apoptosis. Here we show that albumin uptake in primary rat renal epithelial cells is accompanied by a time- and dose-dependent mitochondrial accumulation of the apoptotic factor Bax, down-regulation of the antiapoptotic factor Bcl-xL and mitochondrial membrane depolarization. Ouabain opposes these effects and protects from apoptosis in albumin-exposed proximal tubule cells and podocytes. The efficacy of ouabain as an antiapoptotic and kidney-protective therapeutic tool was then tested in rats with passive Heymann nephritis, a model of proteinuric chronic kidney disease. Chronic ouabain treatment preserved renal function, protected from renal cortical apoptosis, up-regulated Bax, down-regulated Bcl-xL, and rescued from glomerular tubular disconnection and podocyte loss. Thus we have identified a novel clinically feasible therapeutic tool, which has the potential to protect from apoptosis and rescue from loss of functional tissue in chronic proteinuric kidney disease.


Subject(s)
Apoptosis/drug effects , Cardiotonic Agents/therapeutic use , Glomerulonephritis, Membranous/drug therapy , Kidney Glomerulus/drug effects , Kidney Tubules, Proximal/drug effects , Ouabain/therapeutic use , Proteinuria/drug therapy , Animals , Down-Regulation , Drug Evaluation, Preclinical , Humans , Kidney Diseases/physiopathology , Male , Podocytes/physiology , Primary Cell Culture , Rats , Rats, Sprague-Dawley , Sodium-Potassium-Exchanging ATPase , Up-Regulation , bcl-2-Associated X Protein/metabolism , bcl-X Protein/metabolism
2.
Am J Hypertens ; 28(4): 459-68, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25384408

ABSTRACT

BACKGROUND: Casual blood pressure (CBP) is considered a reliable proxy for cardiovascular health. Although the auscultatory technique is the reference standard method for measuring CBP, oscillometric devices are increasingly being used in children. We sought to establish oscillometric CBP normative standards for Swedish children. METHODS: Cross-sectional oscillometric CBP readings were obtained by the Welch Allyn Spot Vital Signs 420 monitor and measured according to the International Guidelines' recommendations. Participants with elevated oscillometric CBP levels underwent verification by the auscultatory method. Ambulatory blood pressure monitoring (ABPM) was used to exclude casual hypertension. Data on 1,470 (772 males) apparently healthy Swedish schoolchildren aged 6-16 years were analyzed and sex-specific reference charts normalized to age or height were constructed. RESULTS: Systolic and diastolic CBP values were significantly higher with age, height, height standard deviation score (SDS), body mass index (BMI), and BMI SDS. Gender differences for systolic CBP were present starting from age of 15 years and revealed significantly higher values in boys than in girls, whereas for diastolic CBP, the differences were apparent at the age of 12 years, with higher values in girls. Increased BMI and BMI SDS were positively associated with CBP levels. Positive parental history of hypertension turned out to be a risk factor for higher systolic and diastolic CBP across all ages. CONCLUSIONS: Our normative standard for CBP can be used for blood pressure screening and control programs in Swedish children. The use of ABPM should be considered to confirm the diagnosis of casual hypertension.


Subject(s)
Blood Pressure Monitoring, Ambulatory/standards , Blood Pressure , Hypertension/diagnosis , Adolescent , Age Factors , Child , Cross-Sectional Studies , Female , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Male , Oscillometry , Predictive Value of Tests , Reference Standards , Risk Factors , Sex Factors , Sweden/epidemiology
3.
Clin Nephrol ; 80(5): 388-94, 2013 Nov.
Article in English | MEDLINE | ID: mdl-22541686

ABSTRACT

Pauci-immune renal limited vasculitis (RLV) is a rare and aggressive autoimmune disease. We retrospectively analyzed the renal outcome of 6 children with biopsy proven RLV. Median age at diagnosis was 10.6 years (range 7.1 - 14.5) and the median follow-up was 4.4 years (range 2.3 - 6.6). At diagnosis, 5 patients were given induction therapy (methylprednisolone + cyclophosphamide pulses) followed by maintenance treatment (prednisolone + azathioprine) while 1 patient received maintenance treatment only. After induction, 4 patients either retained or recovered normal renal function, and 1 patient, in whom short-term plasma exchange was prescribed to try to rescue her renal function, became free from dialysis. Repeated biopsy showed no disease activity; however, renal scarring was evident in all renal specimens. At last follow-up, 2 patients had normal renal function, 3 patients had mild renal insufficiency, and 1 patient had advanced renal failure. In addition, 5 patients were treated for hypertension. Our case series suggests that an initial favorable response to immunosuppressive therapy might not necessarily prevent the occurrence of renal scarring and highlights the importance of regular follow-up.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy , Kidney/physiopathology , Adolescent , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/physiopathology , Child , Female , Follow-Up Studies , Humans , Immunosuppressive Agents , Kidney/pathology , Male , Retrospective Studies
4.
Am J Physiol Renal Physiol ; 299(1): F49-54, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20462969

ABSTRACT

Prolactin is a natriuretic hormone and acts by inhibiting the activity of renal tubular Na(+)-K(+)-ATPase activity. These effects require an intact renal dopamine system. Here, we have studied by which mechanism prolactin and dopamine interact in Sprague-Dawley rat renal tissue. Na(+)-K(+)-ATPase activity was measured as ouabain-sensitive ATP hydrolysis in microdissected renal proximal tubular segments. Intracellular signaling pathways were studied by a variety of different techniques, including Western blotting using phosphospecific antibodies, immunoprecipitation, and biotinylation assays. We found that dopamine and prolactin regulated Na(+)-K(+)-ATPase activity via similar signaling pathways, including protein kinase A, protein kinase C, and phosphoinositide 3-kinase activation. The cross talk between prolactin and dopamine 1-like receptors was explained by a heterologous recruitment of dopamine 1-like receptors to the plasma membrane in renal proximal tubular cells. Prolactin had no effect on Na(+)-K(+)-ATPase activity in spontaneously hypertensive rats, a rat strain with a blunted response to dopamine. These results further emphasize the central role of the renal dopamine system in the interactive regulation of renal tubular salt balance.


Subject(s)
Dopamine/metabolism , Kidney Tubules, Proximal/metabolism , Prolactin/metabolism , Receptors, Dopamine D1/metabolism , Receptors, Prolactin/metabolism , Signal Transduction , Sodium-Potassium-Exchanging ATPase/metabolism , Adenosine Triphosphate/metabolism , Animals , Biotinylation , Blotting, Western , Cells, Cultured , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Disease Models, Animal , Dopamine Antagonists/pharmacology , Enzyme Inhibitors/pharmacology , Hydrolysis , Hypertension/metabolism , Hypertension/physiopathology , Immunoprecipitation , Janus Kinase 2/antagonists & inhibitors , Janus Kinase 2/metabolism , Kidney Tubules, Proximal/cytology , Kidney Tubules, Proximal/drug effects , Male , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Protein Transport , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Rats, Sprague-Dawley , Receptor Cross-Talk , Receptors, Dopamine D1/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors
5.
Am J Physiol Renal Physiol ; 295(4): F1110-6, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18701624

ABSTRACT

Sodium excretion is bidirectionally regulated by dopamine, acting on D1-like receptors (D1R) and angiotensin II, acting on AT1 receptors (AT1R). Since sodium excretion has to be regulated with great precision within a short frame of time, we tested the short-term effects of agonist binding on the function of the reciprocal receptor within the D1R-AT1R complex in renal proximal tubule cells. Exposure of rat renal proximal tubule cells to a D1 agonist was found to result in a rapid partial internalization of AT1R and complete abolishment of AT1R signaling. Similarly, exposure of rat proximal tubule cells and renal tissue to angiotensin II resulted in a rapid partial internalization of D1R and abolishment of D1R signaling. D1R and AT1R were, by use of coimmunoprecipitation studies and glutathione-S-transferase pull-down assays, shown to be partners in a multiprotein complex. Na+-K+-ATPase, the target for both receptors, was included in this complex, and a region in the COOH-terminal tail of D1R (residues 397-416) was found to interact with both AT1R and Na+-K+-ATPase. Results indicate that AT1R and D1R function as a unit of opposites, which should provide a highly versatile and sensitive system for short-term regulation of sodium excretion.


Subject(s)
Calcium Signaling/physiology , Kidney Tubules, Proximal/metabolism , Receptor, Angiotensin, Type 1/metabolism , Receptors, Dopamine D1/metabolism , Sodium/metabolism , Angiotensin II/pharmacology , Animals , Benzazepines/pharmacology , Calcium Signaling/drug effects , Dopamine Agonists/pharmacology , Male , Protein Structure, Tertiary , Rats , Rats, Sprague-Dawley , Receptor Cross-Talk/physiology , Receptor, Angiotensin, Type 1/agonists , Receptor, Angiotensin, Type 1/chemistry , Receptors, Dopamine D1/agonists , Receptors, Dopamine D1/chemistry , Sodium-Potassium-Exchanging ATPase/metabolism , Vasoconstrictor Agents/pharmacology
6.
Pflugers Arch ; 451(6): 793-802, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16217657

ABSTRACT

Desensitization of G-protein-coupled receptors (GPCR) includes receptor endocytosis. This phenomenon is suggested, at least for some receptors, to be associated with receptor resensitization. Here, we examined the role of receptor endocytosis for two different GPCR, the dopamine-1 (D1) receptor and the beta1-adrenoceptor (beta(1)-AR) in renal tissue. The functional role of receptor endocytosis was examined on Na+, K+ -ATPase activity in microdissected proximal tubules from rat kidney. The spatial regulation of endogenous D1 receptors and beta(1)-AR was examined by confocal microscopy techniques in LLCPK cells. Phenylarsine oxide (PAO) an endocytosis inhibitor, attenuated isoproterenol-induced decrease in Na+, K+ -ATPase activity but had no such effect on dopamine-induced decrease in Na+, K+ -ATPase activity. We have previously shown that isoproterenol sensitizes the renal dopamine system, by recruiting silent D1 receptors from the interior of the cell towards the plasma membrane. This effect was attenuated by PAO as well as by cytochalasin D while these substances had no effect on dopamine-induced D1 receptor recruitment. The beta(1)-AR was localized to the plasma membrane in control cells. Isoproterenol induced a rapid internalization of the beta(1)-AR; which was prevented by PAO. The results suggest that endocytosis of beta(1)-AR in renal proximal tubular cells is an important step in signal generation, while endocytosis of proximal tubular D1 receptor is not.


Subject(s)
Kidney/metabolism , Receptors, Dopamine D1/metabolism , Signal Transduction/physiology , Animals , Arsenicals , Cell Line , Cyclic AMP/metabolism , Dopamine/pharmacology , Isoproterenol/pharmacology , Kidney/cytology , Male , Rats , Rats, Sprague-Dawley , Swine
7.
Pediatr Nephrol ; 21(3): 361-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16382324

ABSTRACT

Children with acute pyelonephritis develop polyuria and have reduced maximum urinary concentration capacity. We studied whether these abnormalities are associated with altered urinary excretion of the water channel aquaporin-2 (AQP2) in the renal collecting duct. AQP2 is the main target for antidiuretic action of arginine vasopressin (AVP), and the urinary excretion of this protein is believed to be an index of AVP signaling activity in the kidney. Children with acute pyelonephritis, aged 5-14 years, were examined for urinary flow rate, creatinine clearance, unchallenged urine osmolality, and urinary ion excretion. Urinary excretion of AQP2 was measured by dot immunoblotting technique. Studies were performed in the acute phase of pyelonephritis, in the same children after treatment, and in control patients. At the onset of pyelonephritis, urinary flow rate and solute excretion were increased, but the urinary osmolality was unchanged. The urinary level and urinary excretion of AQP2 was increased in acute pyelonephritis and decreased after treatment. Excretion of aquaporin-3 was unchanged, suggesting that the increase in AQP2 urinary excretion was not due to a shedding of collecting duct cells. The results suggest that a mechanism proximal to the collecting duct may be responsible for the polyuria observed in children with acute pyelonephritis. Increased urinary AQP2 levels suggest that a compensatory activation of apical plasma membrane targeting of AQP2 may occur in pyelonephritis.


Subject(s)
Aquaporin 2/urine , Pyelonephritis/urine , Acute Disease , Adolescent , Aquaporin 3/urine , Arginine Vasopressin , Child , Child, Preschool , Creatinine/urine , Female , Humans , Immunoblotting , Kidney Concentrating Ability , Kidney Tubules, Collecting/physiopathology , Male , Osmolar Concentration , Polyuria/physiopathology , Pyelonephritis/drug therapy , Pyelonephritis/physiopathology , Urine
8.
Kidney Int ; 68(4): 1700-7, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16164646

ABSTRACT

BACKGROUND: Although prolactin affects sodium and water transport across the plasma membrane and interacts with dopamine in the brain, its role in the kidney is unclear. Here we examined the effect of prolactin and its possible interaction with the intrarenal natriuretic hormone dopamine, on proximal tubular Na(+), K(+)-ATPase activity in vitro and renal function in anesthetized rats. METHODS: Na(+), K(+)-ATPase activity was measured as ouabain-sensitive adenosine triphosphate (ATP) hydrolysis in microdissected proximal tubular segments. Renal function was studied during euvolemic conditions by conventional clearance techniques. RESULTS: Prolactin induced a dose-dependent inhibition of proximal tubular Na(+), K(+)-ATPase activity. A maximal inhibitory effect of 48% of control was observed at an in vitro prolactin concentration of 1 microg/mL. This effect was completely abolished by a dopamine D1 receptor antagonist. In tubules preincubated with inhibitors of aromatic amino acid decarboxylase (AADC), the rate-limiting enzyme in renal dopamine formation, prolactin had no effect on Na(+), K(+)-ATPase activity. In rats, prolactin infusion resulted in an increase in urinary sodium, potassium, and water excretion. These effects were also completely abolished by the D1 receptor antagonist. Prolactin had no significant effects on glomerular filtration rate (GFR) or mean arterial blood pressure. CONCLUSION: We conclude that prolactin is a natriuretic hormone which interacts with the renal dopamine system for its effects. The natriuretic response is associated with inhibition of proximal tubular Na(+), K(+)-ATPase activity.


Subject(s)
Dopamine/physiology , Kidney Tubules, Proximal/metabolism , Natriuresis/physiology , Prolactin/physiology , Water-Electrolyte Balance/physiology , Animals , Benzazepines/pharmacology , Dopamine Antagonists/pharmacology , In Vitro Techniques , Kidney Tubules, Proximal/drug effects , Male , Natriuresis/drug effects , Prolactin/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Dopamine D1/antagonists & inhibitors , Receptors, Dopamine D1/physiology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , Water-Electrolyte Balance/drug effects
9.
Pediatr Res ; 55(3): 485-91, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14663154

ABSTRACT

Immature renal tubules are more tolerant to ischemia than mature renal tubules. Here we compared the developmental pattern for some cellular responses evoked by hypoxia and reoxygenation in renal proximal tubules from 10- and 40-day-old rats. Redistribution of Na(+)-K(+)-ATPase from the plasma membrane was studied by confocal microscopy techniques in primary cultured renal proximal tubular cells. The developmental expression of Na(+)-K(+)-ATPase, micro-calpain and heme oxygenase-1 was measured by RT-PCR techniques in rat renal cortex. In response to hypoxia Na(+)-K(+)-ATPase redistribution from the plasma membrane was almost 2-fold increased in cells isolated from mature kidneys compared with cells isolated from immature kidneys. Reoxygenation resulted in a complete reestablishment of Na(+)-K(+)-ATPase in the plasma membrane in the immature but not in the mature cells. The dissociation of Na(+)-K(+)-ATPase from the plasma membrane was associated with a reduced activity and a reduced expression of Na(+)-K(+)-ATPase in the mature but not in the immature tubular cells. The expression of micro-calpain, a factor shown to induce ischemic injury to proximal tubular cells, was significantly lower in the immature compared with the mature kidney, whereas the expression of heme oxygenase-1, a factor shown to protect from renal ischemic injury, was significantly higher in the immature kidney. The results help to explain the increased tolerance of the immature kidney to injury caused by ischemia and reperfusion.


Subject(s)
Hypoxia/pathology , Kidney Tubules, Proximal/pathology , Animals , Animals, Newborn , Base Sequence , Calpain/metabolism , DNA Primers , Heme Oxygenase (Decyclizing)/metabolism , Hypoxia/enzymology , Immunohistochemistry , Kidney Tubules, Proximal/enzymology , Male , Microscopy, Confocal , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Sodium-Potassium-Exchanging ATPase/metabolism
10.
Pflugers Arch ; 445(5): 534-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12634922

ABSTRACT

Renal dopamine1 receptor (D1R) can be recruited from intracellular compartments to the plasma membrane by D1R agonists and endogenous dopamine. This study examines the role of the cytoskeleton for renal D1R recruitment. The studies were performed in LLCPK-1 cells that have the capacity to form dopamine from L-dopa. In approximately 50% of the cells treated with L-dopa the D1R was found to be translocated from intracellular compartments towards the plasma membrane. Disruption of the microtubulin network by nocodazole significantly prevented translocation. In contrast, depolymerization of actin had no effect. In control cells D1R colocalized with NBD-C(6)-ceramide, a trans-Golgi fluorescent marker. This colocalization was disrupted in L-dopa-treated cells. Tetanus toxin, an inhibitor of exocytosis, prevented L-dopa-induced receptor recruitment. L-Dopa treatment resulted in activation of protein kinase C (PKC). To test the functional effect of D1R recruitment, the capacity of D1R agonists to activate PKC was studied. Activation of D1R significantly translocated PKC-alpha from intracellular compartments to the plasma membrane. Disruption of microtubules abolished D1R-mediated - but not phorbol-ester-mediated - translocation of PKC. We conclude that renal D1R recruitment requires an intact microtubulin network and occurs via Golgi-derived vesicles. These newly recruited receptors couple to the PKC signaling pathway.


Subject(s)
Kidney/metabolism , Receptors, Dopamine D1/metabolism , Tubulin/physiology , Animals , Biological Transport , Cytoskeleton/physiology , Dopamine Agonists/pharmacology , Enzyme Activation , Kidney/cytology , LLC-PK1 Cells , Levodopa/pharmacology , Male , Nocodazole/pharmacology , Protein Kinase C/metabolism , Protein Kinase C-alpha , Protein Transport , Rats , Rats, Sprague-Dawley , Receptors, Dopamine D1/agonists , Receptors, Dopamine D1/drug effects , Signal Transduction/drug effects , Subcellular Fractions/metabolism , Swine , Tetanus Toxin/pharmacology , Tissue Distribution , Tubulin/drug effects
11.
Semin Neonatol ; 8(4): 291-9, 2003 Aug.
Article in English | MEDLINE | ID: mdl-15001132

ABSTRACT

The past decade has seen enormous progress in understanding the renal regulation of salt and water homeostasis. Most of the key transporters have been cloned, and their physiological importance has been revealed from studies of children with inherited diseases and from mutagenesis studies on a cellular level. We are beginning to understand the complexity with which the activity of these transporters is regulated by hormones. Studies on experimental animals have uniformly shown that the majority of renal salt and water transporters undergo profound changes in the postnatal period. There is generally a robust increase in the number of transporters expressed in a single tubular cell. Many of the transporters also shift their expression from one isoform to another with a somewhat different function. The short-term regulation of salt and water transporters, the key to a well-functioning homeostatic system, is often blunted in the early postnatal period. Taken together, these findings explain some phenomena well known in infants. The low urinary concentrating capacity can, for example, be at least partially attributed to immaturity of the expression of water channels, sodium losses in preterm infants to low expression of the energy generator for salt transport, Na(+),K(+)-ATPase, and the disposition to acidosis to immaturity of the Na(+)/H(+)exchanger. We propose that further studies on how these transporters are regulated will lead to the improved prevention and treatment of salt water balance disorders in infants.


Subject(s)
Infant, Newborn/physiology , Kidney/physiology , Sodium/metabolism , Water-Electrolyte Balance , Animals , Biological Transport , Body Water/metabolism , Homeostasis , Humans , Infant, Premature , Kidney/growth & development , Kidney/metabolism , Kidney Concentrating Ability , Sodium-Potassium-Exchanging ATPase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...